Moderna Inc (Nasdaq:MRNA) announced Monday that its vaccine appears to be 94.5% effective. The ongoing study is still based on preliminary data, but U.S. sentiment appears high as this is the second major vaccine breakthrough in as many weeks.
This news follows last week’s announcement thata Pfizer Inc. (NYSE:PFE) COVID-19 vaccine appeared to be 90% effective.
Both companies are seeking permission to use within the coming weeks.
Watch the full interview to see if stay-at-home stocks are dead… or becoming disruptive technologies worthy of further investment.